- Home
- AUDC vs MGTX Comparison
AUDC vs MGTX Comparison
Compare AUDC & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUDC
- MGTX
- Stock Information
- Founded
- AUDC 1992
- MGTX 2015
- Country
- AUDC Israel
- MGTX United States
- Employees
- AUDC N/A
- MGTX N/A
- Industry
- AUDC Telecommunications Equipment
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AUDC Utilities
- MGTX Health Care
- Exchange
- AUDC Nasdaq
- MGTX Nasdaq
- Market Cap
- AUDC 282.4M
- MGTX 520.8M
- IPO Year
- AUDC 1999
- MGTX N/A
- Fundamental
- Price
- AUDC $9.30
- MGTX $8.47
- Analyst Decision
- AUDC Buy
- MGTX Strong Buy
- Analyst Count
- AUDC 3
- MGTX 2
- Target Price
- AUDC $11.67
- MGTX $24.00
- AVG Volume (30 Days)
- AUDC 49.1K
- MGTX 541.8K
- Earning Date
- AUDC 07-29-2025
- MGTX 08-11-2025
- Dividend Yield
- AUDC 3.86%
- MGTX N/A
- EPS Growth
- AUDC 57.57
- MGTX N/A
- EPS
- AUDC 0.56
- MGTX N/A
- Revenue
- AUDC $242,474,000.00
- MGTX $34,508,000.00
- Revenue This Year
- AUDC $1.54
- MGTX $365.04
- Revenue Next Year
- AUDC $1.41
- MGTX $73.18
- P/E Ratio
- AUDC $17.23
- MGTX N/A
- Revenue Growth
- AUDC N/A
- MGTX 203.23
- 52 Week Low
- AUDC $7.70
- MGTX $3.85
- 52 Week High
- AUDC $12.72
- MGTX $8.75
- Technical
- Relative Strength Index (RSI)
- AUDC 55.77
- MGTX 76.43
- Support Level
- AUDC $9.57
- MGTX $6.31
- Resistance Level
- AUDC $9.85
- MGTX $8.75
- Average True Range (ATR)
- AUDC 0.17
- MGTX 0.45
- MACD
- AUDC 0.00
- MGTX 0.19
- Stochastic Oscillator
- AUDC 78.87
- MGTX 89.55
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.